Five controversial beliefs about the GP-led secondaries market
Jeff Hammer, global co-head of secondaries at Manulife Investment Management, discusses issues from moral hazard in continuation funds to the ethics of stapled deals with senior editor Adam Le.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Spotlight: A PEI Podcast","authorlink":""},"src":"https:\/\/mcdn.podbean.com\/mf\/web\/68bat4\/JeffHammerPodcast3.mp3","thumb":{"src":"https:\/\/pbcdn1.podbean.com\/imglogo\/image-logo\/3932734\/Spotlight_Logo_Podbean_page-018dadu.jpg"},"title":"Five controversial beliefs about the GP-led secondaries market","link":"javascript:;","id":"item-97928370"}]
